The GINA 2026 update covers primary care management of asthma exacerbations, fatality risk factors, biologic selection, and ...
Asthma is a respiratory condition that requires individualized care, considering each patient’s unique characteristics and therapeutic opportunities. Both primary care professionals and specialists ...
Asthma affects millions of people across the country, including over 4 million kids. Using asthma medicines correctly is ...
For World Asthma Day, GINA is spotlighting the need for greater access to inhaled corticosteroids for everyone, from adults ...
Asthma care continues to develop, particularly in how treatment and long-term management are approached. This article outlines current treatment and management recommendations for patients aged 12 and ...
AstraZeneca’s fixed-dose triple-combination therapy BREZTRI Aerosphere ® (budesonide/glycopyrrolate/formoterol fumarate or BGF 320/36/9.6μg) has been approved in ...
The FDA has approved a fixed-dose triple combination therapy for the maintenance treatment of asthma in adults and children aged 12 years and older, according to a press release from manufacturer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results